OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.210
+0.010 (0.83%)
At close: Apr 28, 2026, 4:00 PM EDT
1.150
-0.060 (-4.96%)
After-hours: Apr 28, 2026, 4:34 PM EDT
OPKO Health Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for OPKO Health stock have an average target of 1.55, with a low estimate of 1.50 and a high estimate of 1.60. The average target predicts an increase of 28.10% from the current stock price of 1.21.
Analyst Consensus: Hold
* Price targets were last updated on Mar 2, 2026.
Analyst Ratings
The average analyst rating for OPKO Health stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $2.25 → $1.5 | Buy | Maintains | $2.25 → $1.5 | +23.97% | Mar 2, 2026 |
| JP Morgan | JP Morgan | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 20, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $2 → $1.6 | Strong Buy → Hold | Downgrades | $2 → $1.6 | +32.23% | Oct 31, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $2.25 | Buy | Maintains | $2.25 | +85.95% | Oct 30, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $2.25 | Buy | Maintains | $2.25 | +85.95% | May 1, 2025 |
Financial Forecast
Revenue This Year
556.73M
from 606.88M
Decreased by -8.26%
Revenue Next Year
580.33M
from 556.73M
Increased by 4.24%
EPS This Year
-0.28
from -0.30
EPS Next Year
-0.25
from -0.28
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 613.6M | 620.0M | ||||||
| Avg | 556.7M | 580.3M | ||||||
| Low | 531.2M | 550.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.1% | 11.4% | ||||||
| Avg | -8.3% | 4.2% | ||||||
| Low | -12.5% | -1.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.22 | -0.11 | |
| Avg | -0.28 | -0.25 | |
| Low | -0.33 | -0.32 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.